· Журналы · Книги · О проекте ·Электронные версии книг издательства “Атмосфера” поступили в продажу Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru ИНТЕРНЕТ-МАГАЗИН    Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print) 2012 / N 2 Клиническая эффективность и безопасность циклесонида (Альвеско) в доказательной базе данных (список литературы) Н.Г. Астафьева, И.В. Гамова, Е.Н. Удовиченко, И.А. Перфилова, Д.Ю. Кобзев 1. Global Initiative for Asthma (GINA) Global Strategy for Asthma Management and Prevention. GINA; 2011. Available from: http://www.ginasthma.org/pdf/GINA_Report_2011.pdf. 2. A. P. Baptist, R. C. Reddy Inhaled corticosteroids for asthma: are they all the same? Journal of Clinical Pharmacy and Therapeutics (2009) 34, 1–12. 3. Mutch E., Nave R., McCracken N., Zech K., Williams F.M. The role of esterases in the metabolism of ciclesonide to desisobutyryl-ciclesonide in human tissue // Biochem. Pharmacol. 2007. Vol. 73. . 10. P. 1657–1664. 4. Nave R.Clinical pharmacokinetic and pharmacodynamic profile of inhaled ciclesonide. Clin Pharmacokinet. 2009;48(4):243-52. 5. Chopra D, Bhandari B, Wardhan N. Ciclesonide--a novel corticosteroid for the management of asthma. Curr Clin Pharmacol. 2012 May;7(2):73-7. 6. Christie P.Ciclesonide: a novel inhaled corticosteroid for asthma. Drugs Today (Barc). 2004 Jul;40(7):569-76. 7. Allen DB. Growth supression by glucocorticoid therapy//Endocrinol.Metabol.Clin.North.Am. 1996; 25: 699–717 8. Dahl R. Ciclesonide for the treatment of asthma // Ther. Clin. Risk Manag. 2006. Vol. 2. № 1. P. 25–38. 9. Nave R. Clinical pharmacokinetic and pharmacodynamic profile of inhaled ciclesonide. Clin Pharmacokinet. 2009;48(4):243-252 10. E.Singas and J. P Karpel Profile of ciclesonide for the maintenance treatment of asthmaTher Clin Risk Manag. 2011; 7: 351-8. 11. Newman S, Salmon A, Nave R, Drollmann A. High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma. Respir Med. 2006;100(3):375-384. 12. Nonaka T, et al. Ciclesonide uptake and metabolism in human alveolar type II epithelial cells (A549). BMC Pharmacol 2007;7:12 13. Stoeck M, Riedel R, Hochhaus G, et al. In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide. J Pharmacol Exp Ther. 2004;309(1):249-258. 14. Nave R., Meyer W., Fuhst R., Zech K. Formation of fatty acid conjugates of ciclesonide active metabolite in the rat lung after 4-week inhalation of ciclesonide // Pulm. Pharmacol. Ther. 2005. Vol. 18. № 6. P. 390–396 15. Nave R., Zech K., Bethke T.D. Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects // Eur. J. Clin. Pharmacol. 2005. Vol. 61. № 3. P. 203–208. 16. Winkler J, Hochhaus G, Derendorf H. How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids. Proc Am Thorac Soc. 2004;1(4):356-363. 17. Derendorf H. Pharmacokinetic and Pharmacodynamic Properties of Inhaled Ciclesonide Journal of Clinical Pharmacology, 2007;47:782-789 18. A. P. Baptist and R. C. Reddy/ Journal of Clinical Pharmacy and Therapeutics (2009) 34, 1–12 . 19. Deeks E.D., Perry C.M. Ciclesonide: a review of its use in the management of asthma // Drugs. 2008. Vol. 68. № 12. P. 1741–1770 20. Nave R, Bethke TD, van Marle SP, Zech K. Pharmacokinetics of [14C] ciclesonide after oral and intravenous administration to healthy subjects. Clin Pharmacokinet. 2004;43(7):479-486 21. Stoeck M., Reiedel R., Hochhaus G. et al. In vitro and in vivo antiinflammatory activity of the new glucocorticoid ciclesonide // J. Pharmacol.Exp. Ther. 2004. Vol. 309. № 1. P. 249–258. 22. Allen DB, Bielory L, Derendorf H, et al. Inhaled corticosteroids: past lessons and future issues. J Allergy Clin Immunol. 2003;112(suppl):S1-S40. 23. Stoeck M, Riedel R, Hochhaus G, et al. In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide. J Pharmacol Exp Ther. 2004;309:249-258. 24. R. Dahl , R. Engelsta¨tter , E. Tre˛bas-Pietras, P. Kuna A 24-week comparison of low-dose ciclesonide and fluticasone propionate in mild to moderate asthma Respiratory Medicine (2010) 104, 1121-1130 25. Dahl R. Ciclesonide for the treatment of asthma. Ther Clin Risk Manag 2006;2(1):25-38.. 26. Deeks ED, Perry CM. Ciclesonide: a review of its use in the management of asthma. Drugs 2008;68(12):1741-70. 27. Barnes PJ. Effect of beta-agonists on inflammatory cells. J Allergy Clin Immunol. 1999 Aug;104(2 Pt 2):S10-7). 28. Horvath G, Mendes ES, Schmid N, Schmid A, Conner GE, Fregien NL, Salathe M, Wanner A. Rapid nongenomic actions of inhaled corticosteroids on long-acting β(2)-agonist transport in the airway. Pulm Pharmacol Ther. 2011 Dec;24(6):654-9. 29. Silversti M., Serpero L., Petecchia L. et al. Cytokine-activated bronchial epithelial cell pro-inflammatory functions are effectively downregulated in vivo by ciclesonide // Pulm. Pharmacol. Ther. 2006. Vol. 19. № 3. P. 210–217. 30. Erin E.M., Zacharasiewisz A.S., Nicholson G.C. et al. Rapid anti-inflammatory effect of inhaled ciclesonide in asthma: a radomised, placebocontrolled study // Chest. 2008. Vol. 134. № 4. P. 740–745.]. 31. Menzies D., Nair A., Hopkinson P., McFarlane L., Lipworth B.J.: Differential anti-inflammatory effects of large and small particle size inhaled corticosteroids in asthma. Allergy 2007, 62:661-667. 32. Silvestri M, Serpero L, Petecchia L, et al. Cytokine-activated bronchial epithelial cell pro-inflammatory functions are effectively downregulated in vitro by ciclesonide. Pulm Pharmacol Ther. 2006;19:210-217. 33. Boero S, Sabatini F, Silvestri M, et al. In vitro downregulation of tumor necrosis factor (TNF)-alpha-induced intercellular adhesion molecule (ICAM)-1 expression on human adult lung fibroblasts by ciclesonide. Proc Am Thorac Soc. 2006;3:A186. 34. Kawayama T, O’Byrne PM, Watson RM, et al. Effects of inhaled ciclesonide on circulating T-helper type 1/T-helper type 2 cells in atopic asthmatics after allergen challenge. Clin Exp Allergy. 2006;36(11):1417-1424. 35. Silvestri M, Morandi F, Pistoia V, Prigione I, Rossi GA.Ciclesonide modulates in vitro allergen-driven activation of blood mononuclear cells and allergen-specific T-cell blasts. Immunol Lett. 2012 Jan 30;141(2):190-6 36. Patel JK, Clifford RL, Deacon K, Knox AJ. Ciclesonide inhibits TNFα- and IL-1β-induced monocyte chemotactic protein-1 (MCP-1/CCL2) secretion from human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2012 Apr;302(8):L785-92.] 37. Wilson AM, Duong M, Pratt B, Dolovich M, O’Byrne PM. Anti-inflammatory effects of once daily low dose inhaled ciclesonide in mild to moderate asthmatic patients. Allergy. 2006; 61(5):537-542. 38. Kanniess F., Richter K., Bohme S. et al. Effect of inhaled ciclesonide on airway responsiveness to inhaled AMP, the composition of induced sputum and exhaled nitric oxide in patients with mild asthma // Pulm. Pharmacol. Ther. 2001. Vol. 14. № 2. P. 141–147. 39. Erin E.M., Zacharasiewisz A.S., Nicholson G.C. et al. Rapid anti-inflammatory effect of inhaled ciclesonide in asthma: a radomised, placebocontrolled study // Chest. 2008. Vol. 134. № 4. P. 740–745.) 40. Zietkowski Z, Bodzenta-Lukaszyk A, Tomasiak MM, Szymanski W, Skiepko R. Effect of ciclesonide and fluticasone on exhaled nitric oxide in patients with mild allergic asthma. Respir Med. 2006;100(9):1651-1656 41. Ciclesonide versus other inhaled steroids for chronic asthma in children and adults. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD007031 42. Singas E, Karpel JP.Profile of ciclesonide for the maintenance treatment of asthma. Ther Clin Risk Manag. 2011;7:351-8. 43. Postma DS, O'Byrne PM, Pedersen S.Comparison of the effect of low-dose ciclesonide and fixed-dose fluticasone propionate and salmeterol combination on long-term asthma control. Chest. 2011 Feb;139(2):311-8 44. Ukena D, Biberger C, Steinijans V, et al. Ciclesonide is more effective than budesonide in the treatment of persistent asthma. Pulm Pharmacol Ther. 2007;20(5):562-570. 45. Adachi M et al. Respirology 2007;12:573-580 46. Manning P, Gibson PG, Lasserson TJ.Ciclesonide versus other inhaled steroids for chronic asthma in children and adults (Review) The Cochrane Library, 2009, Issue 3) http://www.thecochranelibrary.com 47. Hoshino M. Comparison of Effectiveness in Ciclesonide and Fluticasone Propionate on Small Airway Function in Mild Asthma, Allergology International. 2010;59:59-66. 48. Dirkje S. Postma, MD, PhD; Paul M. O’Byrne, MBBCh, FCCP; and Søren Pedersen, MD, PhD Comparison of the Effect of Low-Dose Ciclesonide and Fixed-Dose Fluticasone Propionate and Salmeterol Combination on Long-term Asthma Control CHEST 2011; 139(2):311–318 49. Brian J O’Connor et al. Efficacy and safety of ciclesonide in patients with severe asthma: a 12-week, double-blind, randomized, parallel-group study 5 with long-term (1-year) follow-up Expert Opin. Pharmacother. (2010) 11(17):1-13. 50. Wang W, Li JJ, Foster PS, Hansbro PM, Yang M. Potential therapeutic targets for steroid-resistant asthma. Curr Drug Targets. 2010 Aug;11(8):957-70. 51. Bel EH et al. Collaborators (39) Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax. 2011 Oct;66(10):910-7 52. Robinson CB, Leonard J, Panettieri RA Jr.Drug development for severe asthma: What are the metrics? Pharmacol Ther. 2012 May 22 53. Vogelmeier CF, Hering T, Lewin T, Sander P, Bethke TDEfficacy and safety of ciclesonide in the treatment of 24,037 asthmatic patients in routine medical care. Respir Med. 2011 Feb;105(2):186-94 54. Bateman E, Karpel J, Casale T, Wenzel S, Banerji D. Ciclesonide reduces the need for oral steroid use in adult patients with severe, persistent asthma. Chest. 2006;129(5):117 55. Buhl R, Vinkler I, Magyar P, et al. Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma. Pulm Pharmacol Ther. 2006;19(6):404-412 56. Deborah A Gentile1,2 and David P Skoner New asthma drugs: small molecule inhaled corticosteroids Current Opinion in Pharmacology 2010, 10:260–265. 57. Leif Bjermer Targeting small airways, a step further in asthma management Clin Respir J 2011; 5: 131–135. 58. Burgel P-R.. The role of small airways in obstructive airway diseases. Review. Eur Respir Rev 2011; 20: 119, 23–33. 59.Esposito-Festen J.E., Zanen P., Tiddens H.A., Lammers J.W. Pharmacokinetics of inhaled monodisperse beclomethasone as a function of particle size //Br. J. Clin. Pharmacol. 2007. Vol. 64. . 3. P. 328–334. 60. Schüepp K.G., Jauernig J., Janssens H.M., Tiddens H.A., Straub D.A., Stangl R., Keller M., Wildhaber J.H. In vitro determination of the optimal particle size for nebulized aerosol delivery to infants // J. Aerosol. Med. 2005. Vol. 18. . 2. P. 225–235. 61. Martin RJ. Therapeutic significance of distal airway inflammation in asthma. J Allergy Clin Immunol 2002; 109 (2 Suppl.): S447–60. 62. Contoli M et al. Allergy 2010;65:141-151; 63. Hyde DM et al. J Allergy Clin Immunol 2009;124:S72-77; 64. Wagner EM et al. Am Rev Respir Dis 1990;141:584-588; 65. Ulrik CS, Lange P. Clin Respir J 2010; 66. Hoshino M et al. Allergol Int 2010;59:59-66; 67. Cohen J et al. Eur Respir J 2010 Jul 1. 68. Cohen J et al. Eur Respir J 2008;31:1213-1220; 69. Lucyna Mastalerz, Hanna Kasperkiewicz Effect of inhaled corticosteroids on small airway inflammation in patients with bronchial asthma POLSKIE ARCHIWUM MEDYCYNY WEWNĘTRZNEJ 2011; 121 (7-8) 70. Giovanni A. Rossia, Franklin Cerasolib, Mario Cazzolac Safety of inhaled corticosteroids: Room for improvement Pulmonary Pharmacology & Therapeutics 20 (2007) 23–35. 71. Singas E. , Karpel J.P. Profile of ciclesonide for the maintenance treatment of asthma .Ther Clin Risk Manag. 2011; 7: 351-358. 72. Lipworth BJ, Kaliner MA, LaForce CF, et al. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma. Ann Allergy Asthma Immunol. 2005;94(4):465-472. 73. Derom E, Louis R, Tiesler C, Engelstatter R, Kaufman JM, Joos GF. Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma. Eur Respir J. 2009;33(6):1277-1286. 74. Chylack LT, Jr, Gross GN, Pedinoff A. A randomized, controlled trial to investigate the effect of ciclesonide and beclomethasone dipropionate on eye lens opacity. J Asthma. 2008;45(10):893тАУ902. [PubMed] 75. Agerto€ L., Pedersen S. Lower-leg growth rates in children with asthma during treatment with ciclesonide and fluticasone propionate // Pediatr. Allergy Immunol. 2010. Vol. 21. . 1. Pt. 2. P. e199–e205. 76. David P. Skoner, Jorge Maspero, Donald Banerji, and the Ciclesonide Pediatric Growth Study Group. Assessment of the Long-term Safety of Inhaled Ciclesonide on Growth in Children With Asthma PEDIATRICS Volume 121, Number 1, January 2008 e1-е14 77. Pedersen S, Garcia Garcia ML, Manjra A, Theron I, Engelstätter R . A comparative study of inhaled ciclesonide 160 m g/day and fluticasone propionate 176 m g/day in children with asthma Pediatr Pulmonol . 2006 ; 41 ( 10 ): 954 – 961 78. A. von Berg et al. Comparison of the efficacy and safety of ciclesonide 160 lg once daily vs. budesonide 400 lg once daily in children with asthma Pediatr Allergy Immunol 2007: 18: 391–400 79. Nave R. et al. Biopharm Drug Dispos 2006; 27:197-207 80. Bateman E.D. et al. Pulm Pharmacol Ther 2008;21:264-275 81. Derendorf H. Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide. J Clin Pharmacol. 2007 Jun;47(6):782-9.    [ Содержание выпуска N 2 | Выпуски журнала | Список журналов ]